Peter Bell Email & Phone Number

Tucson, AZ, US

Providing Consulting Services to Life Science and Biotechnology Industry in Technology Evaluation, Product Development and Commercial Strategy

Scottsdale, Arizona, US

Responsible for research and development of assays and systems for cutting edge biomolecule detection utilizing novel nanopore and sensor proteome on chip (SPOC) multiplexed array sensing technologies

Uppsala, Uppland, SE

Responsible for Instrument and Software Development for Gyros Protein Technologies Peptide Synthesizers.

Waltham, MA, US

Directed research and development of products for testing of biopharmaceuticals. Leveraging Next Gen Sequencing (NGS), Capillary electrophoresis, qPCR, and Multi-Attribute Mass Spectrometry to analyze residual host cell DNA, protein, viral contamination, and glycosylation of therapeutic antibodies.

Waltham, MA, US

• Directed Life Science and Drug Discovery tools R&D. Built, led and managed a staff of 65, including Ph.D., M.S. and B.S. Scientists, Engineers and Administrative Staff across several international sites.Directed.
• Directed Program and Portfolio Management
• Coordinated multiple R&D teams across Asia-North America and Europe
• Responsible for licensing, partnering and technology due diligence.
• Implemented idea handling system-and business development portfolio
• Improved product commercialization, leading to $>90M in new product revenues

• Led R&D for Reagents and Instrument Systems Development and IntegrationBuilt a staff of 20, including Ph.D., M.S. and B.S. Scientists, Engineers, Consultants and Administrative
• Led development of 4 new SNP genotyping platforms, with 1st year revenues of > $8M.
• Implemented product development system, improving quality and time to market.
• Reduced material costs and improved methods, saving operations $4M per year.
• Negotiated licensing terms and supply of key raw materials for ultra-high throughput microarray genotyping system, resulting in a 30% reduction in COGS.
• Received 2000 Employee of the Year Award for outstanding contributions to research & product development.

Chicago, US

• Developed, launched and supported GST-Gene Fusion System, PASSPORT Mutation Scanning Kits, and Recombinant Phage Antibody Product lines. Developed and managed a budget of $1.3M, through 10 direct reports.
• Managed Microarray Genotyping Technology as part of 5 year $5M NIST/ATP grant.
• Implemented Mutation Scanning and SNP scoring methods on MegaBACE DNA Sequencer.
• Purified T4 Endonuclease VII, and developed Mutation Scanning Kits for use with ALFexpress, MegaBACE and ABI377 automated DNA sequencing platforms.
• Cloned and expressed recombinant scFv antibodies in E. coli.
• Developed and transferred methods for 20-120 liter fermentation and enzyme purification to pilot plant.

New York, New York, US

• Directed the work of 7 Ph.D., M.S. and B.S. scientists. Launched 54 new products and generated revenues of more than $8.5M/year. Received 1995 Pharmacia Biotech-Global R&D Innovation Prize for novel DNA sequencing.
• Developed and launched FlexiPrep & Sephaglas DNA purification Kits
• Created DNA vectors for the production of recombinant proteins as fusions with Glutathione S-transferase (GST) and (his)6 affinity tags
• Cloned, expressed, purified and commercialized PreScission Protease for recombinant fusion protein processing
• Designed and developed reagents and kits for DNA Cloning, Mutagenesis, Manual and Automated DNA sequencing, and Recombinant Protein Expression
• Designed and taught protein expression and DNA purification practical courses to 24 technical service and sales representatives.

Doctorate (Ph.D.), Oncology, Chemistry, Molecular Biology

Bachelor Of Science (B.S.), Honors Biology